- Home
- LUNG vs DMA Comparison
LUNG vs DMA Comparison
Compare LUNG & DMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUNG
- DMA
- Stock Information
- Founded
- LUNG 1995
- DMA 2011
- Country
- LUNG United States
- DMA United States
- Employees
- LUNG N/A
- DMA N/A
- Industry
- LUNG Industrial Specialties
- DMA Trusts Except Educational Religious and Charitable
- Sector
- LUNG Health Care
- DMA Finance
- Exchange
- LUNG Nasdaq
- DMA Nasdaq
- Market Cap
- LUNG 65.6M
- DMA 78.0M
- IPO Year
- LUNG 2020
- DMA N/A
- Fundamental
- Price
- LUNG $1.76
- DMA $8.69
- Analyst Decision
- LUNG Buy
- DMA
- Analyst Count
- LUNG 7
- DMA 0
- Target Price
- LUNG $7.66
- DMA N/A
- AVG Volume (30 Days)
- LUNG 915.9K
- DMA 34.6K
- Earning Date
- LUNG 07-30-2025
- DMA 01-01-0001
- Dividend Yield
- LUNG N/A
- DMA 2.04%
- EPS Growth
- LUNG N/A
- DMA N/A
- EPS
- LUNG N/A
- DMA N/A
- Revenue
- LUNG $90,549,000.00
- DMA N/A
- Revenue This Year
- LUNG $10.30
- DMA N/A
- Revenue Next Year
- LUNG $14.72
- DMA N/A
- P/E Ratio
- LUNG N/A
- DMA N/A
- Revenue Growth
- LUNG 18.24
- DMA N/A
- 52 Week Low
- LUNG $1.47
- DMA $4.78
- 52 Week High
- LUNG $9.37
- DMA $8.00
- Technical
- Relative Strength Index (RSI)
- LUNG 42.85
- DMA 53.01
- Support Level
- LUNG $1.62
- DMA $8.68
- Resistance Level
- LUNG $1.83
- DMA $8.80
- Average True Range (ATR)
- LUNG 0.12
- DMA 0.07
- MACD
- LUNG 0.07
- DMA 0.00
- Stochastic Oscillator
- LUNG 69.05
- DMA 54.55
About LUNG Pulmonx Corporation
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.
About DMA Destra Multi-Alternative Fund
Destra Multi-Alternative Fund is a non-diversified, closed-end management investment company that operates as an interval fund with a continuous offering of fund shares. The investment objective of the fund is to seek returns from capital appreciation and income with an emphasis on income generation.